Cargando…

Reduction in the Prevalence of Healthcare-Associated Infections in U.S. Acute Care Hospitals, 2015 vs 2011

BACKGROUND: A 2011 prevalence survey conducted by CDC and the Emerging Infections Program (EIP) showed that 1 in 25 hospital patients had ≥1 healthcare-associated infection (HAI). We repeated the survey in 2015 to assess changes in HAI prevalence. METHODS: In EIP sites (CA, CO, CT, GA, MD, MN, NM,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magill, Shelley S, Wilson, Lucy E, Thompson, Deborah L, Ray, Susan M, Nadle, Joelle, Lynfield, Ruth, Janelle, Sarah J, Kainer, Marion A, Greissman, Samantha, Dumyati, Ghinwa, Beldavs, Zintars G, Edwards, Jonathan R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632177/ http://dx.doi.org/10.1093/ofid/ofx162.116

Ejemplares similares

137 Developing an Approach to Evaluating the Quality of Antibiotic Prescribing in Hospitalized Patients with Community-Acquired Pneumonia (CAP) and Non-catheter Associated Urinary Tract Infection (UTI)
por: Fagan, Ryan, et al.
Publicado: (2014)

1859. Prevalence of Antimicrobial Use in US Hospital Patients, 2011 vs. 2015
por: Magill, Shelley S, et al.
Publicado: (2018)

Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015
por: Ansari, Uzma, et al.
Publicado: (2017)

Assessment of the Appropriateness of Antimicrobial Use in US Hospitals
por: Magill, Shelley S., et al.
Publicado: (2021)

Wide Range of Carbapenem-resistant Enterobacteriaceae Incidence and Trends in Emerging Infections Program Surveillance, 2012–2015
por: Duffy, Nadezhda, et al.
Publicado: (2017)

1009. Measuring the quality of fluoroquinolone prescribing in hospitals: results from the Emerging Infections Program Hospital Prevalence Survey Antimicrobial Quality Assessment
por: Magill, Shelley S, et al.
Publicado: (2019)

Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012–2015
por: Bulens, Sandra N., et al.
Publicado: (2018)

Increases in methicillin-sensitive Staphylococcus aureus bloodstream infection incidence, 2016–2019
por: Jackson, Kelly, et al.
Publicado: (2022)

482. Association between Socioeconomic Status Factors and Incidence of Community-Associated Clostridium difficile Infection Utilizing Factor Analysis—United States, 2014–2015
por: Skrobarcek, Kimberly, et al.
Publicado: (2018)

111. Pediatric and Adolescent Sepsis Epidemiology and Clinical Characteristics, Emerging Infections Program, 2014–2015
por: Gokhale, Runa Hatti, et al.
Publicado: (2019)

Socioeconomic Status Factors Associated with Increased Incidence of Community-Associated Clostridium difficile Infection
por: Skrobarcek, Kimberly, et al.
Publicado: (2017)

469. Contributions of Infections among Persons Who Inject Drugs to the Changing Incidence of Healthcare-Associated, Community-Onset Methicillin-Resistant Staphylococcus aureus Infections, 2009–2017
por: Jackson, Kelly A, et al.
Publicado: (2019)

356 Epidemiology of Community-Associated Carbapenem-Resistant Enterobacteriaceae Identified through the Emerging Infections Program
por: Bulens, Sandra, et al.
Publicado: (2014)

Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States
por: Magill, Shelley S., et al.
Publicado: (2015)

1059. Staphylococcus aureus Bacteremia Treatment: Results From Pilot Surveillance in Four US States
por: Kabbani, Sarah, et al.
Publicado: (2018)

275. Evaluation of Vancomycin Prescribing Quality in Hospitalized Pediatric Patients
por: Abanyie-Bimbo, Francisca, et al.
Publicado: (2018)

1836. Characteristics of Nursing Homes Associated With Self-reported Implementation of Centers for Disease Control and Prevention (CDC) Core Elements of Antibiotic Stewardship
por: Thompson, Nicola D, et al.
Publicado: (2018)

1230. Epidemiology and Risk Factors for Recurrent Invasive Methicillin-Resistant Staphylococcus aureus Infection: nine US States, 2006–2013
por: Kracalik, Ian, et al.
Publicado: (2018)

Factors associated with SARS-CoV-2 and community-onset invasive Staphylococcus aureus coinfection, 2020
por: Jackson, Kelly, et al.
Publicado: (2023)

1761. Effect of Carbapenem-Resistant Enterobacteriaceae (CRE) Surveillance Case Definition Change on CRE Epidemiology—Selected US Sites, 2015–2016
por: Duffy, Nadezhda, et al.
Publicado: (2018)

1831. Point Prevalence and Epidemiology of Antimicrobial Use in US Nursing Homes, 2017
por: Thompson, Nicola D, et al.
Publicado: (2018)

Assessment of Health Care Exposures and Outcomes in Adult Patients With Sepsis and Septic Shock
por: Fay, Katherine, et al.
Publicado: (2020)

Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015
por: Walters, Maroya Spalding, et al.
Publicado: (2019)

1641 Evaluation of Co-Infections among Patients with Community-Associated Clostridium difficile Infection
por: Cohen, Jessica, et al.
Publicado: (2014)

Risk Factors for Community-Associated Clostridium difficile Infection in Children
por: Weng, Mark, et al.
Publicado: (2017)

Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs — Six Sites, 2005–2016
por: Jackson, Kelly A., et al.
Publicado: (2018)

Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States
por: Kourtis, Athena P., et al.
Publicado: (2019)

1800 Phenotypic Definitions for Identifying Carbapenemase-Producing Carbapenem-resistant Enterobacteriaceae
por: Chea, Nora, et al.
Publicado: (2014)

Vital Signs: Health Disparities in Hemodialysis-Associated Staphylococcus aureus Bloodstream Infections — United States, 2017–2020
por: Rha, Brian, et al.
Publicado: (2023)

2456. Methicillin-Resistant Staphylococcus aureus Bacteremia 30-Day Mortality During 2020 Compared to 2016-2019: Assessing the Impact of COVID-19
por: Biggs, Holly, et al.
Publicado: (2023)

Evaluation of viral co-infections among patients with community-associated Clostridioides difficile infection
por: Korhonen, Lauren, et al.
Publicado: (2020)

507. Epidemiology of Community-Associated Carbapenemase + Producing Carbapenem-Resistant Enterobacteriacae Identified from the Emerging Infections Program, 2012–2017
por: See, Isaac, et al.
Publicado: (2019)

2458. Carbapenem-resistant Acinetobacter baumannii complex infections and SARS-CoV-2 positivity in 9 U.S. sites, 2020-2022
por: Bulens, Sandra N, et al.
Publicado: (2023)

Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection
por: Dantes, Raymund, et al.
Publicado: (2015)

740. Healthcare-associated invasive Staphylococcus aureus among adults with prior COVID-19-associated hospitalization, 2020
por: Jackson, Kelly A, et al.
Publicado: (2023)

Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations
por: Lessa, Fernanda C., et al.
Publicado: (2014)

Overprescribing of Opioids to Adults by Dentists in the U.S., 2011–2015
por: Suda, Katie J., et al.
Publicado: (2020)

86. Antibiotic-resistant gram-negative bacterial infections among persons with or without a prior positive test for SARS-CoV-2 in 10 U.S. sites, 2020
por: Bulens, Sandra N, et al.
Publicado: (2022)

Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae
por: Chea, Nora, et al.
Publicado: (2015)

Epidemiology of carbapenem-resistant and extended-spectrum beta-lactamase-producing Enterobacterales in US children, 2016–2020
por: Grome, Heather, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2omnqk6v0jj7gvloj5i366ccf2